Edition:
United States

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

0.71USD
4:00pm EDT
Change (% chg)

$-0.04 (-4.70%)
Prev Close
$0.75
Open
$0.75
Day's High
$0.75
Day's Low
$0.71
Volume
20,591
Avg. Vol
21,366
52-wk High
$3.30
52-wk Low
$0.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 21.09 -1.134
Mar '18 28.14 -1.566
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.75 32.14
P/E High - Last 5 Yrs. -- 41.76 46.82
P/E Low - Last 5 Yrs. -- 23.56 24.71
Beta 1.52 0.89 0.87
Price to Sales (TTM) 0.10 4.59 6.55
Price to Book (MRQ) -- 3.64 4.00
Price to Tangible Book (MRQ) -- 5.22 6.10
Price to Cash Flow (TTM) -- 20.18 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.82 1.68
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.81 -5.91
Payout Ratio(TTM) -- 49.52 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -38.55 5.48 7.91
Sales (TTM) vs TTM 1 Yr. Ago -3.29 4.52 6.56
Sales - 5 Yr. Growth Rate 18.96 6.86 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.44 19.36 26.63
EPS (TTM) vs TTM 1 Yr. Ago 69.92 -- --
EPS - 5 Yr. Growth Rate -- 6.47 7.65
Capital Spending - 5 Yr. Growth Rate -70.25 7.62 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.71 2.22 2.22
Current Ratio (MRQ) 0.77 2.97 2.99
LT Debt to Equity (MRQ) -- 8.83 11.31
Total Debt to Equity (MRQ) -- 11.15 14.15
Interest Coverage (TTM) -1.94 40.44 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.57 55.18 54.36
Gross Margin - 5 Yr. Avg. 65.88 53.20 53.16
EBITD Margin (TTM) 15.13 -- --
EBITD - 5 Yr. Avg 4.85 18.67 16.13
Operating Margin (TTM) -17.21 12.80 3.36
Operating Margin - 5 Yr. Avg. -55.06 14.30 11.28
Pre-Tax Margin (TTM) -44.07 13.31 3.79
Pre-Tax Margin - 5 Yr. Avg. -72.09 14.69 11.54
Net Profit Margin (TTM) -44.47 9.92 0.60
Net Profit Margin - 5 Yr. Avg. -68.15 10.95 7.83
Effective Tax Rate (TTM) -- 20.78 20.73
Effective Tax Rate - 5 Yr. Avg. -- 23.93 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 767,468 833,339,537 725,680,242
Net Income/Employee (TTM) -341,287 96,510,060 84,001,075
Receivable Turnover (TTM) 3.26 5.04 5.06
Inventory Turnover (TTM) 5.71 2.55 3.65
Asset Turnover (TTM) 0.64 0.84 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.25 10.12 9.83
Return on Assets - 5 Yr. Avg. -26.42 11.43 10.94
Return on Investment (TTM) -53.53 13.18 12.83
Return on Investment - 5 Yr. Avg. -36.68 14.72 14.05
Return on Equity (TTM) -- 15.14 14.95
Return on Equity - 5 Yr. Avg. -696.55 15.90 15.39
  1 Year 3 Year 5 Year
Sales % 3.70 6.26 18.96
EPS (TTM) % 66.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.29%
# of Holders: 38
Total Shares Held: 3,520,273
3 Mo. Net Change: 1,204,745
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.